Divided into 12 themes that link to in-depth Alzforum articles, this digest sums up the latest<\/a> and will prepare you for just about any development in the coming year<\/strong>.<\/p>\n Some of 2012’s biggest news revolved around antibodies scientists are developing to attack the principal pathological hallmark of the disease\u2014A\u00df<\/strong>. Two big contenders\u2014solanezumab and bapineuzumab\u2014missed their main treatment goals, but solanezumab seemed to slow decline in patients who still only had a mild form of the disease. These results hinted that application at even earlier stages of Alzheimer’s could potentially work. Scientists have put the wheels in motion to test if antibodies can prevent dementia in normal people at high risk for the disease.<\/p>\n An important research and diagnostic tool also hit the clinic this year<\/strong>. The A\u00df plaque tracer Amyvid\u2014which picks up amyloid in brain scans\u2014received FDA approval. The regulatory nod came with a host of issues\u2014who should be scanned, who will pay for it, and what can it tell us?<\/p>\n Alzforum news spanned other neurodegenerative disorders, too<\/strong>. For instance, scientists have developed a better understanding of Chronic Traumatic Encephalopathy, a progressive disorder seen in football players, soldiers, and others who have received repeated blows to the head. Read about these and other stories in \u201cAlzforum’s Top 12 of 2012 http:\/\/www.alzforum.org\/new\/detail.asp?id=3362<\/a>.”<\/p><\/blockquote>\n The Alzheimer Research Forum (www.alzforum.org), founded in 1996, is the web’s most dynamic scientific community dedicated to understanding Alzheimer disease and related disorders. Access to the web site is free to all. The Forum’s editorial priorities are as diverse as the needs of the research community.<\/p>\n The web site reports on the latest scientific findings, from basic research to clinical trials; creates and maintains public databases of essential research data and reagents; and produces discussion forums to promote debate, speed the dissemination of new ideas, and break down barriers across the numerous disciplines that can contribute to the global effort to cure Alzheimer’s disease.<\/p>\n","protected":false},"excerpt":{"rendered":" From the Alzheimer Research Forum media release: Planning to cover dementia research this year? Before the 12 Days of Christmas are over, bone up on the most compelling research trends… Read more »<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[321,4,6],"tags":[195,42,194],"_links":{"self":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/9665"}],"collection":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/comments?post=9665"}],"version-history":[{"count":4,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/9665\/revisions"}],"predecessor-version":[{"id":9678,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/9665\/revisions\/9678"}],"wp:attachment":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/media?parent=9665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/categories?post=9665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/tags?post=9665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"caring_doctor\"](\"http:\/\/therapytoronto.ca\/news\/wp-content\/uploads\/2013\/01\/caring_doctor.jpg\")
Planning to cover dementia research this year?<\/strong> Before the 12 Days of Christmas are over, bone up on the most compelling research trends of 2012 by reading Alzforum’s roundup. It covers everything from surprising gene discoveries and drug trial results to the intricate biology of Alzheimer’s and government research support. Plus, you’ll find some of the big stories to watch for in 2013.<\/p>\n